Centre Hospitalier Universitaire de Nīmes
642
72
90
428
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.1%
84 terminated/withdrawn out of 642 trials
83.6%
-3.0% vs industry average
5%
35 trials in Phase 3/4
0%
1 of 428 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (642)
Study of Sagittal Pelvic Statics in the Sitting Position in Children With Cerebral Palsy
Role: lead
Clinical Development of a Tool for Optimized Self- and Hetero-diagnosis of Stroke Using Artificial Intelligence: Stage1- Collection of Video-clinical Data in a Pragmatic Situation.
Role: lead
Factors Associated With an Evolution in the Quality of Life of Diabetic Patients With Chronic, Wound-free Charcot Foot
Role: lead
Impact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer
Role: lead
Tolerance, Use and Performance of the PEASY Urine Collection Device in Hospitalized Patients
Role: lead
Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain.
Role: lead
Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery
Role: lead
Assessment of NfL and GFAP Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS Patients
Role: lead
Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients With Cardio Renal Syndrome With Severe Renal Impairment
Role: lead
Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis
Role: lead
Evaluation of Transthoracic Echocardiography Parameters and Their Changes in Blood Donor Volunteers
Role: lead
Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis
Role: lead
Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia
Role: lead
Quantification of Motor Compensation Following Biomechanical, Proprioceptive and Physiological Alterations Post-lower Limb Amputation.
Role: lead
Resistance Exercise With Blood Flow Restriction by Vascular Occlusion on Myocardial Function in Heart Failure With Reduced Ejection Fraction
Role: lead
Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning
Role: lead
Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle Syndrome
Role: lead
Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
Role: lead
Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive Pilot Study.
Role: lead
Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4 Chronic Kidney Disease
Role: lead